. home.aspx

home.aspx
   

How Purdue Pharma Is Cashing In On Both Sides Of The Opioid Epidemic

December 16, 2019

One of the company's affiliates is pushing hard to market naloxone, an anti-overdose medication. “You’re in the business of selling medicine that causes addiction and overdoses, and now you’re in the business of selling medicine that treats addiction and overdoses?” asked Dr. Andrew Kolodny, a critic of Purdue Pharma. Meanwhile, a $64 million plan to fight opioid addiction in New Hampshire gets mixed reviews.